NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/25/2026
Back to search
Official data from USPTO
SEAMLESS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
06/25/2026
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
12/14/2023
Registration date
03/17/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2026
Last transaction
06/25/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
LIU, PHILIP HUAI-EN
Law office
L90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "SEAMLESS" in stylized font next to the letter "S" comprised of curved bands.
Holders and representatives
Holders
Seamless Therapeutics GmbH
Representatives
Brian J. Focarino COOLEY LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; biological preparations and biological chemical reagents for use in industry and science; all of the foregoing used for non-medical purposes
Class 5
Pharmaceutical and biological preparations for gene therapies and gene-editing therapiesall for the treatment of genetic and viral diseases; medicalpharmaceutical and biopharmaceutical preparations and substances containing programmable recombinases for the treatment of genetic and viral diseases; pharmaceutical goods and preparationsgene transferregulationmodulation and delivery medications for the treatment of genetic and viral diseases and disorders; productsagentsfor medical purposesfor veterinary purposes in the nature of pharmaceutical preparations for cellulargenome and gene editing therapies to treat geneticoncologicalimmune system-relatedinflammatory disorders and diseases; genome editable enzymes being enzymes for medical purposes; DNA recombinant enzymes being enzymes for medical purposes; DNA editable enzymesespeciallyrecombinases and integrases being enzymes for medical purposes; genome editable enzymes for the treatment of diseases being enzymes for medical purposes; DNA recombinant enzymes for the treatment of diseases being enzymes for medical purposes; DNA editable enzymesin particular recombinases and integrasesfor the treatment of diseases being enzymes for medical purposes
Class 42
Scientific and technological servicesproduct research and testing of pharmaceuticals for cell and gene therapies in the field of pharmaceutical product development for the creation of bioinformatic algorithms and models; development of pharmaceutical preparations and medicinesnone of the foregoing for diagnostics; pharmaceutical product developmentnone of the foregoing for diagnostics; pharmaceutical products development of genome editable enzymes for treatment and not diagnostic purposes; pharmaceutical products development of DNA editable enzymesin particular recombinases and integrasesfor treatment and not diagnostic purposes
Publications
History of USPTO decisions and trademark events.
52 publications found
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/17/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/19/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/19/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/19/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/19/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/17/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/29/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/27/2026
PUBO
PUBLISHED FOR OPPOSITION
01/27/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/21/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/14/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/14/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/30/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
12/30/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/30/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
12/30/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/30/2025
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/30/2025
EXPT
EXPARTE APPEAL TERMINATED
12/22/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/22/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
12/22/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/22/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
12/22/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/22/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
12/22/2025
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
11/10/2025
GECD
ACTION DENYING REQ FOR RECON E-MAILED
11/10/2025
CNCF
ACTION CONTINUING FINAL - COMPLETED
11/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/27/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/27/2025
ALIE
ASSIGNED TO LIE
10/27/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/20/2025
EXPI
EX PARTE APPEAL-INSTITUTED
10/20/2025
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
10/20/2025
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
10/20/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/19/2025
GNFR
FINAL REFUSAL E-MAILED
04/19/2025
CNFR
FINAL REFUSAL WRITTEN
04/19/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/07/2025
RFNT
REFUSAL PROCESSED BY IB
09/30/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/07/2024
RFRR
REFUSAL PROCESSED BY MPU
09/07/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/04/2024
CNRT
NON-FINAL ACTION WRITTEN
09/03/2024
DOCK
ASSIGNED TO EXAMINER
08/22/2024
MAFR
APPLICATION FILING RECEIPT MAILED
08/21/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/21/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/15/2024
Continuous trademark protection
Get notified about every new filing that threatens SEAMLESS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.